GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Other Long-Term Liabilities

Rising Biosciences (Rising Biosciences) Other Long-Term Liabilities : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Other Long-Term Liabilities?

Rising Biosciences's other long-term liabilities for the quarter that ended in . 20 was $0.00 Mil.


Rising Biosciences Other Long-Term Liabilities Historical Data

The historical data trend for Rising Biosciences's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Other Long-Term Liabilities Chart

Rising Biosciences Annual Data
Trend
Other Long-Term Liabilities

Rising Biosciences Quarterly Data
Other Long-Term Liabilities

Rising Biosciences Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Rising Biosciences Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

Rising Biosciences Set To Acquire All Assets from PAO Group

By Marketwired Marketwired 11-07-2018